Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

FDA guidance on inhaler packaging

FDA has issued draft guidance on “inhalation drug products packaged in semipermeable container closure systems.” These products are commonly used in the treatment of asthma or chronic obstructive pulmonary disease.

Over time, chemical impurities can accumulate in the drug from degradation of formulation components, leaching from the container closure system, or entry from the local environment, which can include secondary packaging. The consequences to patients are uncertain but could include bronchospasm.

The draft guidance includes recommendations on appropriate protective secondary packaging; embossing and debossing of the primary container in lieu of paper labels; and the number of unit-dose containers to be contained within each protective secondary package. The guidance applies to drugs already on the market in the United States and to those under development.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Break out of the ordinary: see what’s new in packaging & processing!
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this September to experience a breakthrough in packaging and processing.
REGISTER NOW AND SAVE
Break out of the ordinary: see what’s new in packaging & processing!